Scientists “Completely Eliminate” Leukemia in Preclinical Model
New triple therapy reprograms cancer cell death, helping the immune system destroy tumors. The goal of immunotherapy is to activate a patient’s own immune system to target and destroy tumor cells. In a preclinical study, researchers from the Institut Pasteur and Inserm successfully triggered a potent anti-tumor immune response by reprogramming how malignant B cells [...]
Read more »